Skip to main content
. 2011 Aug 1;4(4):212–221. doi: 10.1593/tlo.11106

Table 2.

Cox Univariate and Multivariate Analyses of RFS of Chk1, Chk2, and MCM3 According to mRNA Expression (Cohort 1) and Protein Expression (Cohort 2).

Cohort 1 (mRNA) Cohort 2 (Protein)


HR (95% CI) P HR (95% CI) P
MCM3 MCM3
Univariate Univariate
Low 1.00 Low 1.00
High 1.98 (1.18–3.31) .01 High 1.82 (1.09–3.04) .022
Multivariate Multivariate
Low 1.00 Low 1.00
High 2.39 (1.30-0.72) .383 High 1.05 (0.60–1.83) .871
Chk1 Chk1
Univariate Univariate
Low 1.00 Low 1.00
High 2.05 (1.33–3.15) .001 High 1.70 (1.08–2.68) .023
Multivariate Multivariate
Low 1.00 Low 1.00
High 1.37 (0.84–2.24) .203 High 1.22 (0.71–2.10 .47
Chk2 Chk2
Univariate Univariate
Low 1.00 Low 1.00
High 1.61 (1.19–2.19) .002 High 1.59 (1.03–2.46) .036
Multivariate Multivariate
Low 1.00 Low 1.00
High 1.52 (1.08–2.13) .015 High 1.21 (0.74–1.97) .448

Multivariate analysis included adjustment for age (continuous), stage (I–II vs III–IV), grade (1–2 vs 3), and residual disease (none vs any, only available for cohort 1).

HHS Vulnerability Disclosure